- Home
- BNTX vs STLA Comparison
BNTX vs STLA Comparison
Compare BNTX & STLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | STLA |
|---|---|---|
| Founded | 2008 | 2021 |
| Country | Germany | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 20.2B |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BNTX | STLA |
|---|---|---|
| Price | $90.25 | $4.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 7 |
| Target Price | ★ $116.80 | $6.71 |
| AVG Volume (30 Days) | 1.1M | ★ 30.7M |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.00 |
| Revenue Next Year | $1.33 | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $79.81 | $3.92 |
| 52 Week High | $124.00 | $12.22 |
Technical Indicators
Market Signals| Indicator | BNTX | STLA |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 48.48 |
| Support Level | $79.81 | $4.30 |
| Resistance Level | $93.89 | $6.09 |
| Average True Range (ATR) | 2.49 | 0.15 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 24.84 | 62.08 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About STLA Stellantis N.V.
Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2025, it sold 5.6 million vehicles, 45%, 26%, and 18% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.